Results 31 to 40 of about 49,535 (243)

Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis

open access: yesPharmacogenomics and Personalized Medicine, 2022
Iram Haq,1,2 Maryam Almulhem,1 Simone Soars,1 David Poulton,2,3 Malcolm Brodlie1,2 1Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; 2Paediatric Respiratory Medicine, Great North ...
Haq I   +4 more
doaj  

The road for survival improvement of cystic fibrosis patients in Arab countries

open access: yesInternational Journal of Pediatrics & Adolescent Medicine, 2015
Cystic fibrosis (CF) is a lethal, monogenic disorder that affects multiple organ sys-tems of the body. The incidence has been described before in the Middle East to be 1 in 2000 to 1 in 5800 live births, and the median survival was estimated to be from ...
Hanaa Banjar, Gerhild Angyalosi
doaj   +1 more source

Mummichog gill and operculum exhibit functionally consistent claudin-10 paralog profiles and Claudin-10c hypersaline response

open access: yesBiology Open, 2021
Claudin (Cldn)-10 tight junction (TJ) proteins are hypothesized to form the paracellular Na+ secretion pathway of hyposmoregulating mummichog (Fundulus heteroclitus) branchial epithelia.
Chun Chih Chen   +4 more
doaj   +1 more source

Synthesis of new pyrazole-pyrimidone derivatives as CFTR potenziators

open access: yes, 2022
reservedIn questa tesi è presentata la sintesi di un gruppo di composti derivanti da K014X, il cui nucleo pirazolo-pirimidonico è stato visto essere particolarmente efficace nel modulare CFTR, e dunque potenzialmente utile nel trattamento di alcune ...
VIZZON, GIULIA
core  

CFTR Modulator Therapy for Rare CFTR Mutants

open access: yes, 2022
Cystic fibrosis (CF), the most common genetic disease among the Caucasian population, is caused by mutations in the gene encoding for the CF transmembrane conductance regulator (CFTR), a chloride epithelial channel whose dysfunction results in severe ...
Alessandra Ghigo   +3 more
core   +1 more source

H+ és HCO3- transzporterek szabályozása humán pancreas ductus sejtekben = Regulation of H+ and HCO3-Transporters in Human Pancreatic Duct Cells [PDF]

open access: yes, 2009
A pancreas nedvben található HCO3- ionok kiválasztásáért a pancreas ductus sejtek felelősek. Jelen pályázatban célul tűztük ki, hogy molekuláris biológiai, transzdukciós és mikrofluorescens technikák felhasználásával megértsük a HCO3- szekréció ...
Rakonczay, Zoltán
core   +1 more source

FUNCIÓN PULMONAR EN FIBROSIS QUÍSTICA

open access: yesNeumología Pediátrica, 2022
La fibrosis quística (FQ) es una enfermedad hereditaria autosómica recesiva, causada por la mutación del gen que codifica la proteína CFTR (cystic fibrosis transmembrane conductance regulator), afecta varios órganos, pero la enfermedad pulmonar es la ...
Hortensia Barrientos
doaj   +1 more source

Sinus Disease Grading on Computed Tomography Before and After Modulating Therapy in Adult Patients with Cystic Fibrosis

open access: yesJournal of the Belgian Society of Radiology, 2022
Objectives: Cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy effects on respiratory function, pulmonary exacerbations and quality of life have been well documented. However, CFTR modulator therapy effects on sinus disease have
Corrado Tagliati   +10 more
doaj   +1 more source

CFTR-R gland data

open access: yes, 2017
CFTR-R gland ...
Milla, Carlos   +11 more
core   +1 more source

Microfluidic Nano‐Assembly of Red‐Blood‐Cell (RBC) Lipids and Components for Engineering Extracellular Vesicles

open access: yesAdvanced Healthcare Materials, EarlyView.
Engineered red blood cell‐derived extracellular vesicles (eRBCEVs) are synthesized via controlled microfluidic assembly from native RBC lipids, enabling tunable encapsulation of proteins, nucleic acids, nanoparticles, and viral vectors. The platform demonstrates reproducible nanoscale architecture, preserved membrane composition, and functional cargo ...
Chiranth K. Nagaraj   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy